CRISPR/Cas9 recombineering‐mediated deep mutational scanning of essential genes in Escherichia coli A Choudhury, JA Fenster, RG Fankhauser, JL Kaar, O Tenaillon, RT Gill Molecular systems biology 16 (3), e9265, 2020 | 31 | 2020 |
Determinants for Efficient Editing with Cas9-Mediated Recombineering in Escherichia coli A Choudhury, RG Fankhauser, EF Freed, EJ Oh, AB Morgenthaler, ... ACS Synthetic Biology 9 (5), 1083-1099, 2020 | 13 | 2020 |
Genomic Deoxyxylulose Phosphate Reductoisomerase (DXR) Mutations Conferring Resistance to the Antimalarial Drug Fosmidomycin in E. coli G Pines, EJ Oh, MC Bassalo, A Choudhury, AD Garst, RG Fankhauser, ... ACS synthetic biology 7 (12), 2824-2832, 2018 | 12 | 2018 |
Predicting drug resistance using deep mutational scanning G Pines, RG Fankhauser, CA Eckert Molecules 25 (9), 2265, 2020 | 10 | 2020 |
Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells R Fankhauser, M Chang, Z Garrison, R Berryman, OM Lucero, A Fuiten, ... Cancers 14 (19), 4921, 2022 | 5 | 2022 |
Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosa AM Fuiten, RG Fankhauser, DJ Smit, MS Stark, TF Enright, MA Wood, ... Pigment cell & melanoma research 34 (6), 1123-1130, 2021 | 4 | 2021 |
Unveiling Cellular Identities and Gene Expression Pathways in Overlapping Myocarditis and Myositis RG Fankhauser, DB Johnson, JJ Moslehi, JM Balko Cancer Immunology Research, OF1-OF2, 2024 | | 2024 |
Proteomic biomarker technology for cancer immunotherapy R Fankhauser, N DePatie, R Berryman, OM Lucero, RP Kulkarni Engineering Technologies and Clinical Translation, 357-397, 2022 | | 2022 |
Altering Parameters of CRISPR/Cas9 Mediated Genome Editing in Escherichia coli Helps Identify Sources of Variation in Editing Efficiency RG Fankhauser | | 2018 |